Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 4
177
Views
1
CrossRef citations to date
0
Altmetric
Short Communications

Acetylcholinesterase inhibitory activity of Ocotea pomaderroides extracts: HPLC-MS/MS characterization and molecular modeling studies

, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 999-1003 | Received 18 Jul 2020, Accepted 16 Oct 2020, Published online: 04 Nov 2020

References

  • Antonio AS, Veiga-Junior VF, Wiedemann LSM. 2020. Ocotea complex: a metabolomic analysis of a Lauraceae genus. Phytochemistry. 173(5):112314
  • Amoo SO, Aremu AO, Moyo M, Staden JV. 2012. Antioxidant and acetylcholinesterase-inhibitory properties of long-term stored medicinal plants. BMC Complement Altern Med. 12:87–95.
  • Ballabeni V, Tognolini M, Giorgio C, Bertoni S, Bruni R, Barocelli E. 2010. Ocotea quixos Lam. essential oil: in vitro and in vivo investigation on its anti-inflammatory properties. Fitoterapia. 81(4):289–295.
  • Bruni R, Medici A, Andreotti E, Fantin C, Muzzoli M, Dehesa M, Romagnoli C, Sacchetti G. 2004. Chemical composition and biological activities of Ishipingo essential oil, a traditional Ecuadorian spice from Ocotea quixos (Lam.) Kosterm. (Lauraceae) flower calices. Food Chem. 85(3):415–421.
  • Cheung J, Rudolph MJ, Burshteyn F, Cassidy MS, Gary EN, Love J, Franklin MC, Height JJ. 2012. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem. 55(22):10282–10286.
  • Conceição RS, Reis IMA, Cerqueira APM, Perez CJ, Junior M, Branco A, Ifa DR, Botura MB. 2020. Rapid structural characterisation of benzylisoquinoline and aporphine alkaloids from Ocotea spixiana acaricide extract by HPTLC-DESI-MSn. Phytochem Anal. 31(6):711–721.
  • Enz A, Amstutz R, Boddeke H, Gmelin G, Malonowski J. 1993. Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer’s disease. Prog. Brain Res. 98:431–445.
  • Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. 2016. Alzheimer's disease: targeting the cholinergic system. Curr Neuropharmacol. 14(1):101–115.
  • Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL. 1999. Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution. FEBS Lett. 463(3):321–326.
  • Maggiora G, Vogt M, Stumpfe D, Bajorath J. 2014. Molecular similarity in medicinal chemistry. J Med Chem. 57(8):3186–3204.
  • Raves ML, Harel M, Pang YP, Silman I, Kozikowski AP, Sussman JL. 1997. Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A. Nat Struct Biol. 4(1):57–63.
  • Remya C, Dileep KV, Tintu I, Variyar EJ, Sadasivan C. 2012. Design of potent inhibitors of acetylcholinesterase using morin as the starting compound. Front Life Sci. 6(3-4):107–117.
  • Rogers DJ, Tanimoto TT. 1960. A Computer Program for Classifying Plants. Science. 132(3434):1115–1118.
  • Xu Y, Colletier JP, Weik M, Jiang H, Moult J, Silman I, Sussman JL. 2008. Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics. Biophys J. 95(5):2500–2511.
  • Zahoor M, Shafiq S, Ullah H, Sadiq A, Ullah F. 2018. Isolation of quercetin and mandelic acid from Aesculus indica fruit and their biological activities. BMC Biochem. 19(1):5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.